Aptose Biosciences Announces Results of Annual and Special Meeting of Shareholders Jun 04, 2019 4:02pm EDT
Aptose to Present New Preclinical Data for CG-806 at the 24th Congress of The European Hematology Association May 16, 2019 10:02am EDT
Aptose Announces Commencement of Previously Announced $20.0 Million Common Share Purchase Agreement with Aspire Capital Fund, LLC May 10, 2019 7:24pm EDT
